Apoptin enhances radiation-induced cell death in poorly responding head and neck squamous cell carcinoma cells

Basic and Clinical Pharmacology and Toxicology

Volumn 106, Issue 2, 2010, Pages 130-134

  Schoop, Remilio A L ^a   Verdegaal, Elizabeth M E ^a   De Jong, Robert J Baatenburg ^b   Noteborn, Mathieu H M ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTIN; CASPASE 3; CYTOCHROME C;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CIRCOVIRIDAE; CLONOGENIC ASSAY; CONTROLLED STUDY; ENZYME ACTIVITY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IONIZING RADIATION; PRIORITY JOURNAL; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

CAPSID PROTEINS; CARCINOMA, SQUAMOUS CELL; CASPASE 3; CELL DEATH; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; CYTOCHROMES C; HEAD AND NECK NEOPLASMS; HUMANS; MITOCHONDRIA; RADIATION-SENSITIZING AGENTS;

CHICKEN ANEMIA VIRUS;

EID: 74549174622     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2009.00482.x     Document Type: Article

References (32)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005 55 : 74 108.
2. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002 52 : 23 47.
3. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med 2001 345 : 1890 1900.
4. Hersey P, Zhang XD, Mhaidat N. Overcoming resistance to apoptosis in cancer therapy. Adv Exp Med Biol 2008 615 : 105 126.
5. Edelman J, Edelman J, Nemunaitis J. Adenoviral p53 gene therapy in squamous cell cancer of the head and neck region. Curr Opin Mol Ther 2003 5 : 611 617.
6. Schoop RA, Baatenburg de Jong RJ, Noteborn MHM. Apoptin induces apoptosis in an oral cancer mouse model. Cancer Biol Ther 2008 7 : 1368 1373.
7. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis 2000 21 : 485 495.
8. Belka C, Schmid B, Marini P, Durand E, Rudner J, Faltin H et al. Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL. Oncogene 2001 20 : 2190 2196.
9. Lee WP, Tai DI, Tsai SL, Yeh CT, Chao Y, Lee SD et al. Adenovirus type 5 E1A sensitizes hepatocellular carcinoma cells to gemcitabine. Cancer Res 2003 63 : 6229 6236.
10. Peng DJ, Sun J, Wang YZ, Tian J, Zhang YH, Noteborn MHM et al. Inhibition of hepatocarcinoma by systemic delivery of Apoptin gene via the hepatic asialoglycoprotein receptor. Cancer Gene Ther 2007 14 : 66 73.
11. Zhang YH, Abrahams PJ, van der Eb AJ, Noteborn MH. The viral protein Apoptin induces apoptosis in UV-C-irradiated cells from individuals with various hereditary cancer-prone syndromes. Cancer Res 1999 59 : 3010 3015.
12. Oro C, Jans DA. The tumour specific pro-apoptotic factor apoptin (Vp3) from chicken anaemia virus. Curr Drug Targets 2004 5 : 179 190.
13. Belka C, Jendrossek V, Pruschy M, Vink S, Verheij M, Budach W. Apoptosis-modulating agents in combination with radiotherapy-current status and outlook. Int J Radiat Oncol Biol Phys 2004 58 : 542 554.
14. Smeets MF, Mooren EH, Abdel-Wahab AH, Bartelink H, Begg AC. Differential repair of radiation-induced DNA damage in cells of human squamous cell carcinoma and the effect of caffeine and cysteamine on induction and repair of DNA double-strand breaks. Radiat Res 1994 140 : 153 160.
15. van der Eb MM, Pietersen AM, Speetjens FM, Kuppen PJ, van de Velde CJ, Noteborn MHM et al. Gene therapy with apoptin induces regression of xenografted human hepatomas. Cancer Gene Ther 2002 9 : 53 61.
16. Schoop RA, Kooistra K, Baatenburg de Jong RJ, Noteborn MHM. Bcl-xL inhibits p53- but not apoptin-induced apoptosis in head and neck squamous cell carcinoma cell line. Int J Cancer 2004 109 : 38 42.
17. Fulda S, Debatin KM. Targeting apoptosis pathways in cancer therapy. Curr Cancer Drug Targets 2004 4 : 569 576.
18. Fischer U, Schulze-Osthoff K. Apoptosis-based therapies and drug targets. Cell Death Differ 2005 12 (Suppl 1 942 961.
19. Danen-van Oorschot AA, van der Eb AJ, Noteborn MHM. The chicken anemia virus-derived protein apoptin requires activation of caspases for induction of apoptosis in human tumor cells. J Virol 2000 74 : 7072 7078.
20. Burek M, Maddika S, Burek CJ, Daniel PT, Schulze-Osthoff K, Los M. Apoptin-induced cell death is modulated by Bcl-2 family members and is Apaf-1 dependent. Oncogene 2006 25 : 2213 2222.
21. Noteborn MHM. Apoptin acts as a tumor-specific killer: potentials for an anti-tumor therapy. Cell Mol Biol (Noisy-le-grand) 2005 51 : 49 60.
22. Backendorf C, Visser AE, de Boer AG, Zimmerman R, Visser M, Voskamp P et al. Apoptin: therapeutic potential of an early sensor of carcinogenic transformation. Annu Rev Pharmacol Toxicol 2008 48 : 143 169.
23. Olijslagers SJ, Zhang YH, Backendorf C, Noteborn MHM. Additive cytotoxic effect of apoptin and chemotherapeutic agents paclitaxel and etoposide on human tumour cells. Basic Clin Pharmacol Toxicol 2007 100 : 127 131.
24. Scata KA, El Deiry WS. p53, BRCA1 and breast cancer chemoresistance. Adv Exp Med Biol 2007 608 : 70 86.
25. Heilman DW, Teodoro JG, Green MR. Apoptin nucleocytoplasmic shutlling is required for cell type-specific localization, apoptosis, and recruitement of the anaphase-promoting complexity/cyclosome to PML bodies. J Virol 2006 80 : 7535 7545.
26. Russo A, Terrasi M, Agnese V, Santini D, Bazan V. Apoptosis: a relevant tool for anticancer therapy. Ann Oncol 2006 17 (Suppl 7 vii115 23.
27. Danen-van Oorschot AAAM, Van der Eb AJ, Noteborn MHM. Bcl-2 stimulates apoptin-induced apoptosis. Adv Exp Med Biol 1999 457 : 245 249.
28. Liu X, Elojeimy S, El-Zawahry AM, Holman DH, Bielawska A. Modulation of ceramide metabolism enhances viral protein apoptin's cytotoxicity in prostate cancer. Mol Ther 2006 14 : 637 646.
29. Gimenez-Bonafe P, Tortosa A, Perez-Tomas R. Overcoming drug resistance by enhancing apoptosis of tumor cells. Curr Cancer Drug Targets 2009 9 : 320 340.
30. Yamamoto H, Ngan CY, Monden M. Cancer cells with survivin. Cancer Sci 2008 99 : 1709 1714.
31. Choe MS, Zhang X, Shin HJ, Shin DM, Chen ZG. Interaction between epidermal growth factor receptor- and cyclooxygenase 2-mediated pathways and its implications for the chemoprevention of head and neck cancer. Mol Cancer Ther 2005 4 : 1448 1455.
32. Lian H, Jin N, Li X, Mi Z, Zhang J, Sun L et al. Induction of an effective anti-tumor immune response and tumor regression by combined administration of IL-18 and Apoptin. Cancer Immunol Immunother 2007 56 : 181 192.